Duke Capital Limited Result of Annual General Meeting

RNS Number : 8254Y

Duke Capital Limited

01 August 2024

 

1 August 2024

 

Duke Capital Limited

 

("Duke Capital", "Duke" or the "Company")

 

Result of Annual General Meeting

 

Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, is pleased to announce that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.

 

Detailed voting results will be made available to view on the Company's website shortly.

 

***ENDS***

 

For further information, please visit www.dukecapital.com or contact:

 

 

Duke Capital Limited	Neil Johnson / Charles Cannon Brookes / Hugo Evans	[phone]
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)	Stephen Keys / Callum Davidson / Michael Johnson	[phone]
Canaccord Genuity Limited (Joint Broker)	Adam James / Harry Rees	[phone]
SEC Newgate (Financial Communications)	Elisabeth Cowell / Alice Cho / Matthew Elliott	+ [phone] [e-mail]

 

 

About Duke Capital

 

Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.

 

Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.

 

Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. Its three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits. Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RAGFLFVITAILIIS